The Cantargia team
Our management group is composed of people with extensive experience of research and pharmaceutical development from both large and small companies. We also have considerable experience in business development with previous experience of licensing pharmaceutical projects.
Close cooperation between management, founders and our in-house and external experts allows us to work effectively not only on development of our own projects, but also on scientific advances and business development. Work is done in close cooperation with an administrative board with extensive experience within our specialised area.
Management

Göran Forsberg, CEO

Liselotte Larsson, COO

Lars Thorsson, VP Clinical Development

David Liberg, CSO

Nedjad Losic, VP Biometrics

Dominique Tersago, CMO

Patrik Renblad, CFO
Research and development

Susanne Magnusson, Director Clinical Development

Camilla Rydberg Millrud, Project Manager Pre Clinical

Gabriel Svensson Birkedal, Senior Scientist Protein Chemistry, CMC

Sara Rattik, Project Manager Pre Clinical

Marie Wallén Öhman, Senior Director Clinical

Caitríona Grönberg, Project Manager Pre Clinical

Dorthe da Graça Thrige, Senior Project Director

Annika Sanfridson, Principal Scientist

Adnan Deronic, IP and Communications Manager

Johan Karlsson, Senior Scientist CMC

Petter Skoog, Pre Clinical Scientist

Henrik Löfvall, Clinical Project Manager

Ida Markholm, Senior Data Manager / Bioinformatician
Administration and Finance

Nina Valkama, Executive Assistant

Johanna Christensen, Financial Controller
Founders

Thoas Fioretos, founder and scientific advisor

Marcus Järås, founder and scientific advisor

Kjell Sjöström, Innovagen, founder, biochemical development